Cargando…

Chosen laboratory markers as a determinant of COVID-19 severity

Detalles Bibliográficos
Autores principales:	Navolokin, Ihor, Tuboltseva, Oleksandra, Navolokina, Alla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788754/ https://www.ncbi.nlm.nih.gov/pubmed/36342033 http://dx.doi.org/10.5603/CJ.a2022.0099

Ejemplares similares

Influence of COVID-19 on cardiac arrest outcomes
por: Zakordonets, Liudmyla, et al.
Publicado: (2023)

Treatment prospects for post-COVID-19 cardiac patients
por: Pruc, Michal, et al.
Publicado: (2022)

Cardiac arrest outcomes in the COVID-19 era
por: Tazerji, Sina Salajegheh, et al.
Publicado: (2022)

Risk of cardiovascular events and death according to COVID-19 reinfection
por: Kozyk, Marko, et al.
Publicado: (2023)

The use of cardiac markers in the prediction of COVID-19
por: Moghadam, Mohamad Gholamhosain, et al.
Publicado: (2023)

The role of C-reactive protein as a prognostic marker in COVID-19
por: Stringer, Dominic, et al.
Publicado: (2021)

Elevated resting heart rate as independent in-hospital prognostic marker in COVID-19
por: Vanoli, Jennifer, et al.
Publicado: (2022)

Critical illness neuropathy in severe COVID-19: a case series
por: Bocci, Tommaso, et al.
Publicado: (2021)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
por: Boussier, Jeremy, et al.
Publicado: (2022)

Burden and prevalence of prognostic factors for severe COVID-19 in Sweden
por: Gémes, Katalin, et al.
Publicado: (2020)

Clinical and neurophysiological characterization of muscular weakness in severe COVID-19
por: Bax, Francesco, et al.
Publicado: (2021)

Distinct cytokine profiles associated with COVID-19 severity and mortality
por: Dorgham, Karim, et al.
Publicado: (2021)

Phospholipid remodeling and its derivatives are associated with COVID-19 severity
por: Wei, Juntong, et al.
Publicado: (2023)

Using excess deaths and testing statistics to determine COVID-19 mortalities
por: Böttcher, Lucas, et al.
Publicado: (2021)

COVID-19-associated severe mono-hemispheric encephalitis in a young infant
por: Nunziata, Francesco, et al.
Publicado: (2022)

Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
por: Yang, Jee Myung, et al.
Publicado: (2020)

Preexisting comorbidities shape the immune response associated with severe COVID-19
por: Kreutmair, Stefanie, et al.
Publicado: (2022)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

MitraClip Insertion to Hasten Recovery from Severe COVID-19
por: Nagaraja, Vinayak, et al.
Publicado: (2020)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
por: Li, Xiaochen, et al.
Publicado: (2020)

Abnormality in the NK-cell population is prolonged in severe COVID-19 patients
por: Leem, Galam, et al.
Publicado: (2021)

CRT-200.05 Correlation Between Left Ventricular Longitudinal Strain and Laboratory Parameters and Clinical Outcomes in Hospitalized COVID-19 Patients
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023)

Procalcitonin as marker for bacterial coinfection among adult COVID-19 patients in a tertiary-care hospital in the Philippines
por: Pesebre, Angelie Lorraine, et al.
Publicado: (2022)

A population-based cohort study of sex and risk of severe outcomes in covid-19
por: Sieurin, Johanna, et al.
Publicado: (2022)

Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases
por: Chochoł-Labun, Joanna, et al.
Publicado: (2021)

Low muscle mass in COVID-19 critically-ill patients: Prognostic significance and surrogate markers for assessment
por: Osuna-Padilla, I.A., et al.
Publicado: (2022)

Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran
por: REZAEI, FATEMEH, et al.
Publicado: (2022)

Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19
por: Priftis, Konstantinos, et al.
Publicado: (2022)

Interplay between demographic, clinical and polygenic risk factors for severe COVID-19
por: Crossfield, Samantha S R, et al.
Publicado: (2022)

COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined
por: Kim, Sohyeon, et al.
Publicado: (2023)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

Diarrhea Is Associated with Increased Severity of Disease in COVID-19: Systemic Review and Metaanalysis
por: Ghimire, Subash, et al.
Publicado: (2021)

Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
por: Zaid, Younes, et al.
Publicado: (2021)

COVID-19 Laboratory Testing/CDC Guidelines
por: McFee, Dr. R.B.
Publicado: (2020)

Association between smoking, e-cigarette use and severe COVID-19: a cohort study
por: Gao, Min, et al.
Publicado: (2022)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
por: Bauer, Ann Z., et al.
Publicado: (2020)

Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report
por: Manral, Ishita, et al.
Publicado: (2021)

The relationship between COVID-19’s severity and ischemic stroke: a systematic review and meta-analysis
por: Lu, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjq0anb7l61miu65fbc9o15k91